Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Microgravity may increase drug bioavailability, potentially reaching up to 80%.

Alopecia areata management involves explaining the condition, using treatments like steroids and immunotherapy, and providing support like counseling and wigs.

Ethosomes with 30% ethanol effectively deliver dutasteride to hair follicles for treating hair loss.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

A new method was developed to purify finasteride for better medical use.

Dextroamphetamine may help treat alopecia areata.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Dutasteride injections can help treat hair loss in men and women.

New therapies for alopecia areata show potential but need more research.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Alopecia areata patients have eye issues and need regular eye exams.

Hair loss is caused by mechanical, thermal, and metabolic stress, not just hormones.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Sudden, unusual hair loss may indicate serious underlying health issues.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

STAR particles are safe, comfortable, and effective for enhancing drug delivery through the skin.

AMT may cause hair loss and changing dWAT activity could help treat it.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

A rare ovarian tumor caused high male hormone levels, but surgery fixed it.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.